Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/05/2003EP0782441B1 Pharmaceutical control of inflammation
03/05/2003EP0754060B1 New combination of a beta-receptor blocker and a local anaesthetic
03/05/2003EP0731688B1 Aerosol drug formulations for use with non-cfc propellants
03/05/2003EP0728143B1 Oncoprotein protein kinase
03/05/2003EP0724457B1 Radiation sensitization using texaphyrins
03/05/2003EP0690863B1 Tetracyclic compounds as dopamine agonists
03/05/2003EP0575524B1 Products for treating glaucoma
03/05/2003EP0554352B1 A method for transplanting cells into the brain and therapeutic uses therefor
03/05/2003CN1401001A 5HT3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof
03/05/2003CN1400976A Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates
03/05/2003CN1400975A 嘌呤衍生物 Purine derivatives
03/05/2003CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
03/05/2003CN1400973A Novel biarylcarboxamides
03/05/2003CN1400970A Substituted arylpyrazines
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives
03/05/2003CN1400909A Pharmaceutical composition
03/05/2003CN1400908A Combinations comprising dipeptidylpepidase IV inhibitors and antidiabetic agents
03/05/2003CN1400906A Treatment of congestive heart failure by pretreated autologous blood
03/05/2003CN1400905A Novel therapeutic use of enoxaparin
03/05/2003CN1400904A Selective estrogen receptor modulators in combination with estrogens
03/05/2003CN1400903A Novel combination of non sedative anti histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjuncitivitis
03/05/2003CN1400902A Oral formulation comprising an inhibitor compound of the ileal bile transport and on HMG CO-A reductase inhibitor
03/05/2003CN1400901A Method for reducing or tliminating smoking
03/05/2003CN1400900A Remedies or preventives for digestive diseases containing diaminotrifluoromethylpyridine derivatives
03/05/2003CN1400899A Use of 2-methyl thiazolidin-2, 4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/05/2003CN1400897A Transdermal delivery LASOFOXIFENE
03/05/2003CN1400896A Ibuprofen containing active agent preparation
03/05/2003CN1400895A Remedies for degenerative arthritis
03/05/2003CN1400892A Pharmaceutical composition for intramuscular injection containing loxoprofen
03/05/2003CN1400871A Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability of undesired permeability of the
03/05/2003CN1400870A Improved pediatric formula and methods for providing nutrition and improving tolerance
03/05/2003CN1400869A Inulin products with improved nutritional properties
03/05/2003CN1400220A Two kinds of cDNA with activity capable of extensively inhibiting HIV and its expression, separation and purification method in protokaryon
03/05/2003CN1400209A New quinaldinic acid derivative with 7-(7-aminomethyl-5-azaspiro [2,4] heplane) substituent and its preparation method
03/05/2003CN1400018A Medicine for curing adiposis, diabetes and related diseases
03/05/2003CN1400010A Medicine for external application for stopping pain and its preparation method
03/05/2003CN1400004A Chinese medicine preparation for curing chronic conjunctivitis
03/05/2003CN1400003A Medicine composition for curing hepatitis
03/05/2003CN1400001A Medicine for curing cough and asthma
03/05/2003CN1400000A External Chinese medicine adhesive plaster for curing appendicitis and its preparation method
03/05/2003CN1399995A Chinese medicine preparation containing cortex fraxini and its preparation method
03/05/2003CN1399992A Medicine for curing gastritis, gastric and duodenal ulcer
03/05/2003CN1399988A Anti-tumor action of hymidine and research of its action mechanism
03/05/2003CN1399978A Chinese medicine liquor for curing pointed condyloma
03/05/2003CN1399977A Medicine for curing prolapse of lumbar intervertebral disc and its preparation method
03/05/2003CN1399975A Medicine for curing peptic ulcer and its preparation method
03/05/2003CN1399965A Medicine for curing side effect resulted from chemical therapy and radiation therapy and its production method
03/05/2003CN1399964A Capsule for curing facial paralysis and its preparation method
03/05/2003CN1399963A Diammonium glycyrrhizanate transfusion preparation
03/05/2003CN1399962A Pralidoxime chloride powder injection and its preparation method
03/05/2003CN1399961A Medicine for curing toothache
03/05/2003CN1399960A Medicine for promoting recovery of renal function
03/05/2003CN1399959A Etomidate fatty emulsion injection preparation method
03/05/2003CN1399958A Taxol nano magnetic target preparation and its preparation method
03/05/2003CN1399957A Application of shikonin and its derivative in pharmaceutical industry
03/05/2003CN1399916A Application of dihydromyricetin in preparation of food, cosmetics or medicine
03/05/2003CN1102596C 5H-thiazole [3,2-a] pyrmidine derivatives
03/05/2003CN1102595C Penems and their derivatives
03/05/2003CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound
03/05/2003CN1102592C 2R, 4S, S,S-and 2S, 4R, S,S-hydroxyitraconazole
03/05/2003CN1102580C Arylethenesulfonamide derivatives and drug composition containing the same
03/05/2003CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid
03/05/2003CN1102410C Mupirocin calcium salt emulsifiable paste composition
03/05/2003CN1102406C Medicine for treating burn (scald) and preparation process
03/05/2003CN1102398C Eye ointment for curing myopia and its production process
03/05/2003CN1102396C Production process of compound meilingzhihua health food series
03/05/2003CN1102392C Quick soluble breviscapine B tablet its preparation
03/05/2003CN1102391C Crystalline pharmaceutical product
03/05/2003CN1102390C Fase dissolving galanthamine hydrobromide tablet
03/05/2003CN1102389C External-use drops for earand its prepn. method
03/05/2003CN1102388C Inhibition of smooth muscle migration and proliferation with hydrogen carbazole compounds
03/05/2003CN1102387C Novel pharmaceuticalcomposition for control and treatment of anorectal and colonic diseases
03/05/2003CN1102386C Combination of 5-HT uptake inhibitor with selective 5-HT1A antagonist
03/05/2003CN1102385C Rapidly disintegrating medicinal form of tramadol or tramadol salt
03/05/2003CN1102384C Patch containing isosorbide dinitrate
03/05/2003CN1102376C Improved anti dandruff shampoo
03/05/2003CN1102337C Fungicidal active compound combinations
03/05/2003CA2356438A1 Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers
03/04/2003WO2002022148A1 Wild apple polyphenol and process for producing the same
03/04/2003US6529377 Integrated cooling system
03/04/2003US6528685 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
03/04/2003US6528681 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
03/04/2003US6528677 Selective retinoid agonists
03/04/2003US6528676 Estrogenic compounds as anti-mitotic agents
03/04/2003US6528664 Synthetic methods for polyphenols
03/04/2003US6528653 Thienopyrrolidinones
03/04/2003US6528637 Fatty acid synthase mRNA binding protein
03/04/2003US6528634 Aiolos gene
03/04/2003US6528628 Making 6-O-alkyl erythromycin A or its oxime starting from the novel intermediate erythromycin A 9-oxime
03/04/2003US6528543 Glucokinase activating for treating type II diabetes; acylurea compound, phenylacetyl-substituted; 1-(2-(3-chloro-phenyl)-3cyclopentyl-propionyl)-3-methyl-urea
03/04/2003US6528542 Adjustment concentration
03/04/2003US6528541 Administering to the cow at least one of an ester of methionine, an ester of methionine amide, and an ester of hydroxy analogue of methionine, or salt of atleast one ester to increase milk production
03/04/2003US6528540 Administering by injection
03/04/2003US6528539 And propylene glycol dicaprate/dicaprylate hydrophobic agent
03/04/2003US6528538 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharamaceutical compositions and preparation process
03/04/2003US6528535 Bicyclic inhibitors of protein farnesyl transferase
03/04/2003US6528534 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
03/04/2003US6528533 Treating or preventing neuronal damage associated with neurological diseases; hydrazide based compounds containing the group -N-N-CO-X- where X is C,O,S,or N
1 ... 5547 5548 5549 5550 5551 5552 5553 5554 5555 5556 5557 5558 5559 5560 5561 5562 5563 5564 5565 5566 5567 ... 7860